|
1
|
Moreira PVL, de Arruda Neta ADCP, Ferreira
SS, Ferreira FELL, de Lima RLFC, de Toledo Vianna RP, de Araújo JM,
de Alencar Rodrigues RE, da Silva Neto JM and O'Flaherty M:
Coronary heart disease and stroke mortality trends in Brazil
2000-2018. PLoS One. 16(e253639)2021.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Roger VL, Go AS, Lloyd-Jones DM, Adams RJ,
Berry JD, Brown TM, Carnethon MR, Dai S, de Simone G, Ford ES, et
al: Heart disease and stroke statistics-2011 update: A report from
the American Heart Association. Circulation. 123:e18–e209.
2011.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Hausenloy DJ and Yellon DM: Myocardial
ischemia-reperfusion injury: A neglected therapeutic target. J Clin
Invest. 123:92–100. 2013.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Ogura Y, Ouchi N, Ohashi K, Shibata R,
Kataoka Y, Kambara T, Kito T, Maruyama S, Yuasa D, Matsuo K, et al:
Therapeutic impact of follistatin-like 1 on myocardial ischemic
injury in preclinical models. Circulation. 126:1728–1738.
2012.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Verma S, Fedak PW, Weisel RD, Butany J,
Rao V, Maitland A, Li RK, Dhillon B and Yau TM: Fundamentals of
reperfusion injury for the clinical cardiologist. Circulation.
105:2332–2336. 2002.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Jennings RB, Sommers HM, Smyth GA, Flack
HA and Linn H: Myocardial necrosis induced by temporary occlusion
of a coronary artery in the dog. Arch Pathol. 70:68–78.
1960.PubMed/NCBI
|
|
7
|
Heusch G: Myocardial stunning and
hibernation revisited. Nat Rev Cardiol. 18:522–536. 2021.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Caiazzo G, Musci RL, Frediani L, Umińska
J, Wanha W, Filipiak KJ, Kubica J and Navarese EP: State of the
art: No-Reflow phenomenon. Cardiol Clin. 38:563–573.
2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Nagao K, Ooiwa K and Kanmatsuse K:
Reperfusion arrhythmia. Ryoikibetsu Shokogun Shirizu. 277–281.
1996.PubMed/NCBI(In Japanese).
|
|
10
|
Yellon DM and Hausenloy DJ: Myocardial
reperfusion injury. N Engl J Med. 357:1121–1135. 2007.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Yang CF: Clinical manifestations and basic
mechanisms of myocardial ischemia/reperfusion injury. Ci Ji Yi Xue
Za Zhi. 30:209–215. 2018.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Javat D, Heal C, Banks J, Buchholz S and
Zhang Z: Regional to tertiary inter-hospital transfer versus
in-house percutaneous coronary intervention in acute coronary
syndrome. PLoS One. 13(e198272)2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Li Y, Li Y, Li B, Liu Y, Zhang J, Kuang W,
Lu J, Cao Z, Cui J, Fan Z, et al: Antiplatelet therapy with
integrated traditional Chinese and western medicine for use in
myocardial Ischemia-Reperfusion injury: A review of clinical
applications and mechanisms. Evid Based Complement Alternat Med.
2021(7409094)2021.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Li Q, Shen L, Wang Z, Jiang HP and Liu LX:
Tanshinone IIA protects against myocardial ischemia reperfusion
injury by activating the PI3K/Akt/mTOR signaling pathway. Biomed
Pharmacother. 84:106–114. 2016.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Hotchkiss RS, Strasser A, McDunn JE and
Swanson PE: Cell death. N Engl J Med. 361:1570–1583.
2009.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Kalogeris T, Baines CP, Krenz M and
Korthuis RJ: Cell biology of ischemia/reperfusion injury. Int Rev
Cell Mol Biol. 298:229–317. 2012.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Li R, Jia Z and Trush MA: Defining ROS in
biology and medicine. React Oxyg Species (Apex). 1:9–21.
2016.PubMed/NCBI View Article : Google Scholar
|
|
18
|
González-Montero J, Brito R, Gajardo AI
and Rodrigo R: Myocardial reperfusion injury and oxidative stress:
Therapeutic opportunities. World J Cardiol. 10:74–86.
2018.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Kandula V, Kosuru R, Li H, Yan D, Zhu Q,
Lian Q, Ge RS, Xia Z and Irwin MG: Forkhead box transcription
factor 1: Role in the pathogenesis of diabetic cardiomyopathy.
Cardiovasc Diabetol. 15(44)2016.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Li H, Xia Z, Chen Y, Qi D and Zheng H:
Mechanism and therapies of oxidative Stress-Mediated cell death in
ischemia reperfusion injury. Oxid Med Cell Longev.
2018(2910643)2018.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Xia Z, Chen Y, Fan Q and Xue M: Oxidative
stress-mediated reperfusion injury: Mechanism and therapies. Oxid
Med Cell Longev. 2014(373081)2014.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Xia Z, Chen Y, Fan Q, Xue M and Liu KX:
Oxidative stress-mediated reperfusion injury 2014. Oxid Med Cell
Longev. 2015(689416)2015.PubMed/NCBI View Article : Google Scholar
|
|
23
|
García N, Zazueta C and Aguilera-Aguirre
L: Oxidative stress and inflammation in cardiovascular disease.
Oxid Med Cell Longev. 2017(5853238)2017.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Goldhaber JI and Weiss JN: Oxygen free
radicals and cardiac reperfusion abnormalities. Hypertension.
20:118–1127. 1992.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Brookes PS, Yoon Y, Robotham JL, Anders MW
and Sheu SS: Calcium, ATP, and ROS: A mitochondrial love-hate
triangle. Am J Physiol Cell Physiol. 287:C817–C833. 2004.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Chen Y, Liu C, Zhou P, Li J, Zhao X, Wang
Y, Chen R, Song L, Zhao H and Yan H: Coronary endothelium No-Reflow
injury is associated with ROS-Modified mitochondrial fission
through the JNK-Drp1 signaling pathway. Oxid Med Cell Longev.
2021(6699516)2021.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Pena E, Brito J, El Alam S and Siques P:
Oxidative stress, kinase activity and inflammatory implications in
right ventricular hypertrophy and heart failure under hypobaric
hypoxia. Int J Mol Sci. 21(6421)2020.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Cadenas S: ROS and redox signaling in
myocardial ischemia-reperfusion injury and cardioprotection. Free
Radic Biol Med. 117:76–89. 2018.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Kura B, Szeiffova BB, Kalocayova B, Sykora
M and Slezak J: Oxidative stress-responsive MicroRNAs in heart
injury. Int J Mol Sci. 21(358)2020.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Wu MY, Yiang GT, Liao WT, Tsai AP, Cheng
YL, Cheng PW, Li CY and Li CJ: Current mechanistic concepts in
ischemia and reperfusion injury. Cell Physiol Biochem.
46:1650–1667. 2018.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Li H, Yao W, Liu Z, Xu A, Huang Y, Ma XL,
Irwin MG and Xia Z: Hyperglycemia abrogates ischemic
postconditioning cardioprotection by impairing
AdipoR1/Caveolin-3/STAT3 signaling in diabetic rats. Diabetes.
65:942–955. 2016.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Su W, Zhang Y, Zhang Q, Xu J, Zhan L, Zhu
Q, Lian Q, Liu H, Xia ZY, Xia Z and Lei S: N-acetylcysteine
attenuates myocardial dysfunction and postischemic injury by
restoring caveolin-3/eNOS signaling in diabetic rats. Cardiovasc
Diabetol. 15(146)2016.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Jeddi S, Gheibi S, Kashfi K, Carlström M
and Ghasemi A: Protective effect of intermediate doses of hydrogen
sulfide against myocardial ischemia-reperfusion injury in obese
type 2 diabetic rats. Life Sci. 256(117855)2020.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Wang T, Mao X, Li H, Qiao S, Xu A, Wang J,
Lei S, Liu Z, Ng KF, Wong GT, et al: N-Acetylcysteine and
allopurinol up-regulated the Jak/STAT3 and PI3K/Akt pathways via
adiponectin and attenuated myocardial postischemic injury in
diabetes. Free Radic Biol Med. 63:291–303. 2013.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Xue R, Lei S, Xia ZY, Wu Y, Meng Q, Zhan
L, Su W, Liu H, Xu J, Liu Z, et al: Selective inhibition of PTEN
preserves ischaemic post-conditioning cardioprotection in
STZ-induced Type 1 diabetic rats: Role of the PI3K/Akt and
JAK2/STAT3 pathways. Clin Sci (Lond). 130:377–392. 2016.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Wu Q, Wang T, Chen S, Zhou Q, Li H, Hu N,
Feng Y, Dong N, Yao S and Xia Z: Cardiac protective effects of
remote ischaemic preconditioning in children undergoing tetralogy
of fallot repair surgery: A randomized controlled trial. Eur Heart
J. 39:1028–1037. 2018.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Wang TT, Shi MM, Liao XL, Li YQ, Yuan HX,
Li Y, Liu X, Ning DS, Peng YM, Yang F, et al: Overexpression of
inducible nitric oxide synthase in the diabetic heart compromises
ischemic postconditioning. J Mol Cell Cardiol. 129:144–153.
2019.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Liu Y, Paterson M, Baumgardt SL, Irwin MG,
Xia Z, Bosnjak ZJ and Ge ZD: Vascular endothelial growth factor
regulation of endothelial nitric oxide synthase phosphorylation is
involved in isoflurane cardiac preconditioning. Cardiovasc Res.
115:168–178. 2019.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Trafford AW, Díaz ME, Negretti N and
Eisner DA: Enhanced Ca2+ current and decreased Ca2+ efflux restore
sarcoplasmic reticulum Ca2+ content after depletion. Circ Res.
81:477–4784. 1997.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Eisner D, Bode E, Venetucci L and Trafford
A: Calcium flux balance in the heart. J Mol Cell Cardiol.
58:110–117. 2013.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Chen S and Li S: The Na+/Ca²+ exchanger in
cardiac ischemia/reperfusion injury. Med Sci Monit. 18:RA161–RA165.
2012.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Murphy E and Steenbergen C: Mechanisms
underlying acute protection from cardiac ischemia-reperfusion
injury. Physiol Rev. 88:581–609. 2008.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Aghaei M, Motallebnezhad M, Ghorghanlu S,
Jabbari A, Enayati A, Rajaei M, Pourabouk M, Moradi A, Alizadeh AM
and Khori V: Targeting autophagy in cardiac ischemia/reperfusion
injury: A novel therapeutic strategy. J Cell Physiol.
234:16768–16778. 2019.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Hotta Y, Ishikawa N, Ohashi N and Matsui
K: Effects of SM-20550, a selective Na+-H+ exchange inhibitor, on
the ion transport of myocardial mitochondria. Mol Cell Biochem.
219:83–90. 2001.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Talukder MA, Zweier JL and Periasamy M:
Targeting calcium transport in ischaemic heart disease. Cardiovasc
Res. 84:345–352. 2009.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Chen C, Lu W, Wu G, Lv L, Chen W, Huang L,
Wu X, Xu N and Wu Y: Cardioprotective effects of combined therapy
with diltiazem and superoxide dismutase on myocardial
ischemia-reperfusion injury in rats. Life Sci. 183:50–59.
2017.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Kook H, Hong SJ, Yang KS, Lee S, Kim JS
and Park CG: Comparison of nebivolol versus diltiazem in improving
coronary artery spasm and quality of life in patients with
hypertension and vasospastic angina: A prospective, randomized,
double-blind pilot study. PLoS One. 15(e239039)2020.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Lodha AR, Pillai A, Sheth K and Hiremath
J: A retrospective cohort study exploring diltiazem as a
pharmaco-enhancer for tacrolimus, in a post-heart transplant
setting. Clin Transplant. 34(e14100)2020.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Bou-Teen D, Kaludercic N, Weissman D,
Turan B, Maack C, Di Lisa F and Ruiz-Meana M: Mitochondrial ROS and
mitochondria-targeted antioxidants in the aged heart. Free Radic
Biol Med. 167:109–124. 2021.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Yu J, Wu J, Xie P, Maimaitili Y, Wang J,
Xia Z, Gao F, Zhang X and Zheng H: Sevoflurane postconditioning
attenuates cardiomyocyte hypoxia/reoxygenation injury via restoring
mitochondrial morphology. Peerj. 4(e2659)2016.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Boengler K, Kosiol M, Mayr M, Schulz R and
Rohrbach S: Mitochondria and ageing: Role in heart, skeletal muscle
and adipose tissue. J Cachexia Sarcopenia Muscle. 8:349–369.
2017.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Fieni F, Johnson DE, Hudmon A and Kirichok
Y: Mitochondrial Ca2+ uniporter and CaMKII in heart. Nature.
513:E1–E2. 2014.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Santulli G, Xie W, Reiken SR and Marks AR:
Mitochondrial calcium overload is a key determinant in heart
failure. Proc Natl Acad Sci USA. 112:11389–11394. 2015.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Cheng Y, Xia Z, Han Y and Rong J: Plant
natural product formononetin protects rat cardiomyocyte h9c2 cells
against oxygen glucose deprivation and reoxygenation via inhibiting
ROS formation and promoting GSK-3β phosphorylation. Oxid Med Cell
Longev. 2016(2060874)2016.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Shintani-Ishida K, Inui M and Yoshida K:
Ischemia-reperfusion induces myocardial infarction through
mitochondrial Ca²+ overload. J Mol Cell Cardiol.
53:233–239. 2012.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Kulek AR, Anzell A, Wider JM, Sanderson TH
and Przyklenk K: Mitochondrial quality control: Role in cardiac
models of lethal ischemia-reperfusion injury. Cells.
9(214)2020.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Chang JC, Lien CF, Lee WS, Chang HR, Hsu
YC, Luo YP, Jeng JR, Hsieh JC and Yang KT: Intermittent hypoxia
prevents myocardial mitochondrial Ca 2+ Overload and
cell death during ischemia/reperfusion: The role of reactive oxygen
species. Cells-Basel. 8(564)2019.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Obeng E: Apoptosis (programmed cell death)
and its signals-A review. Braz J Biol. 81:1133–1143.
2021.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Slee EA, Adrain C and Martin SJ:
Executioner caspase-3, -6, and -7 perform distinct, non-redundant
roles during the demolition phase of apoptosis. J Biol Chem.
276:7320–7326. 2001.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Schlegel RA and Williamson P:
Phosphatidylserine, a death knell. Cell Death Differ. 8:551–563.
2001.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Xu X, Lai Y and Hua ZC: Apoptosis and
apoptotic body: Disease message and therapeutic target potentials.
Biosci Rep. 39(BSR20180992)2019.PubMed/NCBI View Article : Google Scholar
|
|
62
|
D'Arcy MS: Cell death: A review of the
major forms of apoptosis, necrosis and autophagy. Cell Biol Int.
43:582–592. 2019.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Dong Y, Chen H, Gao J, Liu Y, Li J and
Wang J: Molecular machinery and interplay of apoptosis and
autophagy in coronary heart disease. J Mol Cell Cardiol. 136:27–41.
2019.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Wajant H: The Fas signaling pathway: More
than a paradigm. Science. 296:1635–1636. 2002.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Kischkel FC, Hellbardt S, Behrmann I,
Germer M, Pawlita M, Krammer PH and Peter ME:
Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a
death-inducing signaling complex (DISC) with the receptor. EMBO J.
14:5579–5588. 1995.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Teringova E and Tousek P: Apoptosis in
ischemic heart disease. J Transl Med. 15(87)2017.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Del Re DP, Amgalan D, Linkermann A, Liu Q
and Kitsis RN: Fundamental mechanisms of regulated cell death and
implications for heart disease. Physiol Rev. 99:1765–1817.
2019.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Condorelli G, Roncarati R, Ross JJ Jr,
Pisani A, Stassi G, Todaro M, Trocha S, Drusco A, Gu Y, Russo MA,
et al: Heart-targeted overexpression of caspase3 in mice increases
infarct size and depresses cardiac function. Proc Natl Acad Sci
USA. 98:9977–9982. 2001.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Lee P, Sata M, Lefer DJ, Factor SM, Walsh
K and Kitsis RN: Fas pathway is a critical mediator of cardiac
myocyte death and MI during ischemia-reperfusion in vivo. Am J
Physiol Heart Circ Physiol. 284:H456–H463. 2003.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Jeremias I, Kupatt C, Martin-Villalba A,
Habazettl H, Schenkel J, Boekstegers P and Debatin KM: Involvement
of CD95/Apo1/Fas in cell death after myocardial ischemia.
Circulation. 102:915–920. 2000.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Kosuru R, Cai Y, Kandula V, Yan D, Wang C,
Zheng H, Li Y, Irwin MG, Singh S and Xia Z: AMPK contributes to
cardioprotective effects of pterostilbene against myocardial
ischemia-reperfusion injury in diabetic rats by suppressing cardiac
oxidative stress and apoptosis. Cell Physiol Biochem. 46:1381–1397.
2018.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Forini F, Kusmic C, Nicolini G, Mariani L,
Zucchi R, Matteucci M, Iervasi G and Pitto L: Triiodothyronine
prevents cardiac ischemia/reperfusion mitochondrial impairment and
cell loss by regulating miR30a/p53 axis. Endocrinology.
155:4581–4590. 2014.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Lin CL, Tseng HC, Chen RF, Chen WP, Su MJ,
Fang KM and Wu ML: Intracellular zinc release-activated
ERK-dependent GSK-3β-p53 and Noxa-Mcl-1 signaling are both involved
in cardiac ischemic-reperfusion injury. Cell Death Differ.
18:1651–1663. 2011.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Zhang C, Shi J, Qian L, Zhang C, Wu K,
Yang C, Yan D, Wu X and Liu X: Nucleostemin exerts anti-apoptotic
function via p53 signaling pathway in cardiomyocytes. In Vitro Cell
Dev Biol Anim. 51:1064–1071. 2015.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Li M, Wang D, He J, Chen L and Li H:
Bcl-XL: A multifunctional anti-apoptotic protein.
Pharmacol Res. 151(104547)2020.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Hochhauser E, Kivity S, Offen D, Maulik N,
Otani H, Barhum Y, Pannet H, Shneyvays V, Shainberg A, Goldshtaub
V, et al: Bax ablation protects against myocardial
ischemia-reperfusion injury in transgenic mice. Am J Physiol Heart
Circ Physiol. 284:H2351–H2359. 2003.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Chen Z, Chua CC, Ho YS, Hamdy RC and Chua
BH: Overexpression of Bcl-2 attenuates apoptosis and protects
against myocardial I/R injury in transgenic mice. Am J Physiol
Heart Circ Physiol. 280:H2313–H2320. 2001.PubMed/NCBI View Article : Google Scholar
|
|
78
|
Zhang D, He Y, Ye X, Cai Y, Xu J, Zhang L,
Li M, Liu H, Wang S and Xia Z: Activation of autophagy inhibits
nucleotide-binding oligomerization domain-like receptor protein 3
inflammasome activation and attenuates myocardial
ischemia-reperfusion injury in diabetic rats. J Diabetes Investig.
11:1126–1136. 2020.PubMed/NCBI View Article : Google Scholar
|
|
79
|
Cai Y, Ying F, Liu H, Ge L, Song E, Wang
L, Zhang D, Hoi CTE, Xia Z and Irwin MG: Deletion of Rap1 protects
against myocardial ischemia/reperfusion injury through suppressing
cell apoptosis via activation of STAT3 signaling. FASEB J.
34:4482–4496. 2020.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Peng K, Chen WR, Xia F, Liu H, Meng XW,
Zhang J, Liu HY, Xia ZY and Ji FH: Dexmedetomidine post-treatment
attenuates cardiac ischaemia/reperfusion injury by inhibiting
apoptosis through HIF-1α signalling. J Cell Mol Med. 24:850–861.
2020.PubMed/NCBI View Article : Google Scholar
|
|
81
|
Gao S, Wang R, Dong S, Wu J, Perek B, Xia
Z, Yao S and Wang T: Inactivation of TOPK caused by hyperglycemia
blocks diabetic heart sensitivity to sevoflurane postconditioning
by impairing the PTEN/PI3K/Akt signaling. Oxid Med Cell Longev.
2021(6657529)2021.PubMed/NCBI View Article : Google Scholar
|
|
82
|
Pang L, Cai Y, Tang EH, Yan D, Kosuru R,
Li H, Irwin MG, Ma H and Xia Z: Cox-2 inhibition protects against
hypoxia/reoxygenation-induced cardiomyocyte apoptosis via
Akt-dependent enhancement of iNOS expression. Oxid Med Cell Longev.
2016(3453059)2016.PubMed/NCBI View Article : Google Scholar
|
|
83
|
Korshunova AY, Blagonravov ML, Neborak EV,
Syatkin SP, Sklifasovskaya AP, Semyatov SM and Agostinelli E:
BCL2-regulated apoptotic process in myocardial ischemia-reperfusion
injury (Review). Int J Mol Med. 47:23–36. 2021.PubMed/NCBI View Article : Google Scholar
|
|
84
|
Liu J, Liu M and Chen L: Novel
pathogenesis: Regulation of apoptosis by Apelin/APJ system. Acta
Biochim Biophys Sin (Shanghai). 49:471–478. 2017.PubMed/NCBI View Article : Google Scholar
|
|
85
|
Qi Z and Chen L: Endoplasmic reticulum
stress and autophagy. Adv Exp Med Biol. 1206:167–177.
2019.PubMed/NCBI View Article : Google Scholar
|
|
86
|
Sanderson TH, Gallaway M and Kumar R:
Unfolding the unfolded protein response: Unique insights into brain
ischemia. Int J Mol Sci. 16:7133–7142. 2015.PubMed/NCBI View Article : Google Scholar
|
|
87
|
Chen X, Wang Y, Xie X, Chen H, Zhu Q, Ge
Z, Wei H, Deng J, Xia Z and Lian Q: Heme oxygenase-1 reduces
Sepsis-Induced endoplasmic reticulum stress and acute lung injury.
Mediators Inflamm. 2018(9413876)2018.PubMed/NCBI View Article : Google Scholar
|
|
88
|
Zhang YM, Wang CY, Zheng FC, Gao FF, Chen
YC, Huang ZQ, Xia ZY, Irwin MG, Li WQ, Liu XP, et al: Effects of
N-n-butyl haloperidol iodide on the rat myocardial sarcoplasmic
reticulum Ca(2+)-ATPase during ischemia/reperfusion. Biochem
Biophys Res Commun. 425:426–430. 2012.PubMed/NCBI View Article : Google Scholar
|
|
89
|
Liu Y, Baumgardt SL, Fang J, Shi Y, Qiao
S, Bosnjak ZJ, Vásquez-Vivar J, Xia Z, Warltier DC, Kersten JR and
Ge ZD: Transgenic overexpression of GTP cyclohydrolase 1 in
cardiomyocytes ameliorates post-infarction cardiac remodeling. Sci
Rep. 7(3093)2017.PubMed/NCBI View Article : Google Scholar
|
|
90
|
Su RY, Geng XY, Yang Y and Yin HS:
Nesfatin-1 inhibits myocardial ischaemia/reperfusion injury through
activating Akt/ERK pathway-dependent attenuation of endoplasmic
reticulum stress. J Cell Mol Med. 25:5050–5059. 2021.PubMed/NCBI View Article : Google Scholar
|
|
91
|
Vekich JA, Belmont PJ, Thuerauf DJ and
Glembotski CC: Protein disulfide isomerase-associated 6 is an
ATF6-inducible ER stress response protein that protects cardiac
myocytes from ischemia/reperfusion-mediated cell death. J Mol Cell
Cardiol. 53:259–267. 2012.PubMed/NCBI View Article : Google Scholar
|
|
92
|
Glembotski CC: Roles for ATF6 and the
sarco/endoplasmic reticulum protein quality control system in the
heart. J Mol Cell Cardiol. 71:11–15. 2014.PubMed/NCBI View Article : Google Scholar
|
|
93
|
Dai B, Qiao L, Zhang M, Cheng L, Zhang L,
Geng L, Shi C, Zhang M, Sui C, Shen W, et al: LncRNA AK054386
functions as a ceRNA to sequester miR-199 and induce sustained
endoplasmic reticulum stress in hepatic reperfusion injury. Oxid
Med Cell Longev. 2019(8189079)2019.PubMed/NCBI View Article : Google Scholar
|
|
94
|
Gao P, Yan Z and Zhu Z:
Mitochondria-Associated endoplasmic reticulum membranes in
cardiovascular diseases. Front Cell Dev Biol.
8(604240)2020.PubMed/NCBI View Article : Google Scholar
|
|
95
|
Zhou J, Ahmad F, Parikh S, Hoffman NE,
Rajan S, Verma VK, Song J, Yuan A, Shanmughapriya S, Guo Y, et al:
Loss of adult cardiac myocyte GSK-3 leads to mitotic catastrophe
resulting in fatal dilated cardiomyopathy. Circ Res. 118:1208–1222.
2016.PubMed/NCBI View Article : Google Scholar
|
|
96
|
Zeeshan HM, Lee GH, Kim HR and Chae HJ:
Endoplasmic reticulum stress and associated ROS. Int J Mol Sci.
17(327)2016.PubMed/NCBI View Article : Google Scholar
|
|
97
|
Zhang G, Wang X, Gillette TG, Deng Y and
Wang ZV: Unfolded protein response as a therapeutic target in
cardiovascular disease. Curr Top Med Chem. 19:1902–1917.
2019.PubMed/NCBI View Article : Google Scholar
|
|
98
|
Song S, Tan J, Miao Y and Zhang Q:
Crosstalk of ER stress-mediated autophagy and ER-phagy: Involvement
of UPR and the core autophagy machinery. J Cell Physiol.
233:3867–3874. 2018.PubMed/NCBI View Article : Google Scholar
|
|
99
|
Verfaillie T, Rubio N, Garg AD, Bultynck
G, Rizzuto R, Decuypere JP, Piette J, Linehan C, Gupta S, Samali A
and Agostinis P: PERK is required at the ER-mitochondrial contact
sites to convey apoptosis after ROS-based ER stress. Cell Death
Differ. 19:1880–1891. 2012.PubMed/NCBI View Article : Google Scholar
|
|
100
|
Carreras-Sureda A, Jaña F, Urra H, Durand
S, Mortenson DE, Sagredo A, Bustos G, Hazari Y, Ramos-Fernández E,
Sassano ML, et al: Non-canonical function of IRE1α determines
mitochondria-associated endoplasmic reticulum composition to
control calcium transfer and bioenergetics. Nat Cell Biol.
21:755–767. 2019.PubMed/NCBI View Article : Google Scholar
|
|
101
|
Shi B, Ma M, Zheng Y, Pan Y and Lin X:
MTOR and Beclin1: Two key autophagy-related molecules and their
roles in myocardial ischemia/reperfusion injury. J Cell Physiol.
234:12562–12568. 2019.PubMed/NCBI View Article : Google Scholar
|
|
102
|
Wang S, Wang C, Yan F, Wang T, He Y, Li H,
Xia Z and Zhang Z: N-Acetylcysteine attenuates diabetic myocardial
ischemia reperfusion injury through inhibiting excessive autophagy.
Mediators Inflamm. 2017(9257291)2017.PubMed/NCBI View Article : Google Scholar
|
|
103
|
Klionsky DJ, Abdel-Aziz AK, Abdelfatah S,
Abdellatif M, Abdoli A, Abel S, Abeliovich H, Abildgaard MH, Abudu
YP, Acevedo-Arozena A, et al: Guidelines for the use and
interpretation of assays for monitoring autophagy (4th
edition)1. Autophagy. 17:1–382. 2021.PubMed/NCBI View Article : Google Scholar
|
|
104
|
Ouyang C, You J and Xie Z: The interplay
between autophagy and apoptosis in the diabetic heart. J Mol Cell
Cardiol. 71:71–80. 2014.PubMed/NCBI View Article : Google Scholar
|
|
105
|
Levine B and Yuan J: Autophagy in cell
death: An innocent convict? J Clin Invest. 115:2679–2688.
2005.PubMed/NCBI View Article : Google Scholar
|
|
106
|
Sala-Mercado JA, Wider J, Undyala VV,
Jahania S, Yoo W, Mentzer RJ, Gottlieb RA and Przyklenk K: Profound
cardioprotection with chloramphenicol succinate in the swine model
of myocardial ischemia-reperfusion injury. Circulation. 122 (11
Suppl):S179–S184. 2010.PubMed/NCBI View Article : Google Scholar
|
|
107
|
Wang Y, Zhou L, Su W, Huang F, Zhang Y,
Xia ZY, Xia Z and Lei S: Selective inhibition of PKCβ2 restores
ischemic Postconditioning-Mediated cardioprotection by modulating
autophagy in diabetic rats. J Diabetes Res.
2020(2408240)2020.PubMed/NCBI View Article : Google Scholar
|
|
108
|
Chen Z, Hu Z, Lu Z, Cai S, Gu X, Zhuang H,
Ruan Z, Xia Z, Irwin MG, Feng D and Zhang L: Differential microRNA
profiling in a cellular hypoxia reoxygenation model upon
posthypoxic propofol treatment reveals alterations in autophagy
signaling network. Oxid Med Cell Longev.
2013(378484)2013.PubMed/NCBI View Article : Google Scholar
|
|
109
|
Abdrakhmanov A, Gogvadze V and Zhivotovsky
B: To Eat or to Die: Deciphering selective forms of autophagy.
Trends Biochem Sci. 45:347–364. 2020.PubMed/NCBI View Article : Google Scholar
|
|
110
|
Cong Y, Dinesh KN, Mauthe M, Verlhac P and
Reggiori F: Manipulation of selective macroautophagy by pathogens
at a glance. J Cell Sci. 133(jcs240440)2020.PubMed/NCBI View Article : Google Scholar
|
|
111
|
Schuck S: Microautophagy-distinct
molecular mechanisms handle cargoes of many sizes. J Cell Sci.
133(jcs246322)2020.PubMed/NCBI View Article : Google Scholar
|
|
112
|
Yang Q, Wang R and Zhu L:
Chaperone-Mediated autophagy. Adv Exp Med Biol. 1206:435–452.
2019.PubMed/NCBI View Article : Google Scholar
|
|
113
|
Zhu H and He L: Beclin 1 biology and its
role in heart disease. Curr Cardiol Rev. 11:229–237.
2015.PubMed/NCBI View Article : Google Scholar
|
|
114
|
Brady NR, Hamacher-Brady A, Yuan H and
Gottlieb RA: The autophagic response to nutrient deprivation in the
hl-1 cardiac myocyte is modulated by Bcl-2 and sarco/endoplasmic
reticulum calcium stores. FEBS J. 274:3184–3197. 2007.PubMed/NCBI View Article : Google Scholar
|
|
115
|
Ma X, Liu H, Foyil SR, Godar RJ,
Weinheimer CJ, Hill JA and Diwan A: Impaired autophagosome
clearance contributes to cardiomyocyte death in
ischemia/reperfusion injury. Circulation. 125:3170–3181.
2012.PubMed/NCBI View Article : Google Scholar
|
|
116
|
Ma X, Liu H, Foyil SR, Godar RJ,
Weinheimer CJ and Diwan A: Autophagy is impaired in cardiac
ischemia-reperfusion injury. Autophagy. 8:1394–1396.
2012.PubMed/NCBI View Article : Google Scholar
|
|
117
|
Manganelli V, Matarrese P, Antonioli M,
Gambardella L, Vescovo T, Gretzmeier C, Longo A, Capozzi A,
Recalchi S, Riitano G, et al: Raft-like lipid microdomains drive
autophagy initiation via AMBRA1-ERLIN1 molecular association within
MAMs. Autophagy. 17:2528–2548. 2021.PubMed/NCBI View Article : Google Scholar
|
|
118
|
Sun L, Ma W, Gao W, Xing Y, Chen L, Xia Z,
Zhang Z and Dai Z: Propofol directly induces caspase-1-dependent
macrophage pyroptosis through the NLRP3-ASC inflammasome. Cell
Death Dis. 10(542)2019.PubMed/NCBI View Article : Google Scholar
|
|
119
|
Ball DP, Taabazuing CY, Griswold AR, Orth
EL, Rao SD, Kotliar IB, Vostal LE, Johnson DC and Bachovchin DA:
Caspase-1 interdomain linker cleavage is required for pyroptosis.
Life Sci Alliance. 3(e202000664)2020.PubMed/NCBI View Article : Google Scholar
|
|
120
|
Toldo S, Mauro AG, Cutter Z and Abbate A:
Inflammasome, pyroptosis, and cytokines in myocardial
ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol.
315:H1553–H1568. 2018.PubMed/NCBI View Article : Google Scholar
|
|
121
|
Tsuchiya K: Inflammasome-associated cell
death: Pyroptosis, apoptosis, and physiological implications.
Microbiol Immunol. 64:252–269. 2020.PubMed/NCBI View Article : Google Scholar
|
|
122
|
Frank D and Vince JE: Pyroptosis versus
necroptosis: Similarities, differences, and crosstalk. Cell Death
Differ. 26:99–114. 2019.PubMed/NCBI View Article : Google Scholar
|
|
123
|
Liu X, Zhang Z, Ruan J, Pan Y, Magupalli
VG, Wu H and Lieberman J: Inflammasome-activated gasdermin D causes
pyroptosis by forming membrane pores. Nature. 535:153–158.
2016.PubMed/NCBI View Article : Google Scholar
|
|
124
|
He WT, Wan H, Hu L, Chen P, Wang X, Huang
Z, Yang ZH, Zhong CQ and Han J: Gasdermin D is an executor of
pyroptosis and required for interleukin-1β secretion. Cell Res.
25:1285–1298. 2015.PubMed/NCBI View Article : Google Scholar
|
|
125
|
Yue RC, Lu SZ, Luo Y, Wang T, Liang H,
Zeng J, Liu J and Hu HX: Calpain silencing alleviates myocardial
ischemia-reperfusion injury through the NLRP3/ASC/Caspase-1 axis in
mice. Life Sci. 233(116631)2019.PubMed/NCBI View Article : Google Scholar
|
|
126
|
Djulbegovic MB and Uversky VN:
Ferroptosis-an iron- and disorder-dependent programmed cell death.
Int J Biol Macromol. 135:1052–1069. 2019.PubMed/NCBI View Article : Google Scholar
|
|
127
|
Liu Q, Zhang D, Hu D, Zhou X and Zhou Y:
The role of mitochondria in NLRP3 inflammasome activation. Mol
Immunol. 103:115–124. 2018.PubMed/NCBI View Article : Google Scholar
|
|
128
|
Kawaguchi M, Takahashi M, Hata T, Kashima
Y, Usui F, Morimoto H, Izawa A, Takahashi Y, Masumoto J, Koyama J,
et al: Inflammasome activation of cardiac fibroblasts is essential
for myocardial ischemia/reperfusion injury. Circulation.
123:594–604. 2011.PubMed/NCBI View Article : Google Scholar
|
|
129
|
Ding S, Liu D, Wang L, Wang G and Zhu Y:
Inhibiting MicroRNA-29a protects myocardial Ischemia-Reperfusion
injury by targeting SIRT1 and suppressing oxidative stress and
NLRP3-Mediated pyroptosis pathway. J Pharmacol Exp Ther.
372:128–135. 2020.PubMed/NCBI View Article : Google Scholar
|
|
130
|
Wang C, Zhu L, Yuan W, Sun L, Xia Z, Zhang
Z and Yao W: Diabetes aggravates myocardial ischaemia reperfusion
injury via activating Nox2-related programmed cell death in an
AMPK-dependent manner. J Cell Mol Med. 24:6670–6679.
2020.PubMed/NCBI View Article : Google Scholar
|
|
131
|
Popov SV, Maslov LN, Naryzhnaya NV,
Mukhomezyanov AV, Krylatov AV, Tsibulnikov SY, Ryabov VV, Cohen MV
and Downey JM: The role of pyroptosis in ischemic and reperfusion
injury of the heart. J Cardiovasc Pharmacol Ther. 26:562–574.
2021.PubMed/NCBI View Article : Google Scholar
|
|
132
|
Yang WS and Stockwell BR: Ferroptosis:
Death by lipid peroxidation. Trends Cell Biol. 26:165–176.
2016.PubMed/NCBI View Article : Google Scholar
|
|
133
|
Dixon SJ, Lemberg KM, Lamprecht MR, Skouta
R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS,
et al: Ferroptosis: An iron-dependent form of nonapoptotic cell
death. Cell. 149:1060–1072. 2012.PubMed/NCBI View Article : Google Scholar
|
|
134
|
Sun X, Ou Z, Chen R, Niu X, Chen D, Kang R
and Tang D: Activation of the p62-Keap1-NRF2 pathway protects
against ferroptosis in hepatocellular carcinoma cells. Hepatology.
63:173–184. 2016.PubMed/NCBI View Article : Google Scholar
|
|
135
|
Yan N and Zhang J: Iron metabolism,
ferroptosis, and the links with alzheimer's disease. Front
Neurosci. 13(1443)2019.PubMed/NCBI View Article : Google Scholar
|
|
136
|
Weiland A, Wang Y, Wu W, Lan X, Han X, Li
Q and Wang J: Ferroptosis and its role in diverse brain diseases.
Mol Neurobiol. 56:4880–4893. 2019.PubMed/NCBI View Article : Google Scholar
|
|
137
|
Hu Z, Zhang H, Yang SK, Wu X, He D, Cao K
and Zhang W: Emerging role of ferroptosis in acute kidney injury.
Oxid Med Cell Longev. 2019(8010614)2019.PubMed/NCBI View Article : Google Scholar
|
|
138
|
Yu H, Guo P, Xie X, Wang Y and Chen G:
Ferroptosis, a new form of cell death, and its relationships with
tumourous diseases. J Cell Mol Med. 21:648–657. 2017.PubMed/NCBI View Article : Google Scholar
|
|
139
|
Su LJ, Zhang JH, Gomez H, Murugan R, Hong
X, Xu D, Jiang F and Peng ZY: Reactive oxygen Species-Induced lipid
peroxidation in apoptosis, autophagy, and ferroptosis. Oxid Med
Cell Longev. 2019(5080843)2019.PubMed/NCBI View Article : Google Scholar
|
|
140
|
Stoyanovsky DA, Tyurina YY, Shrivastava I,
Bahar I, Tyurin VA, Protchenko O, Jadhav S, Bolevich SB, Kozlov AV,
Vladimirov YA, et al: Iron catalysis of lipid peroxidation in
ferroptosis: Regulated enzymatic or random free radical reaction?
Free Radic Biol Med. 133:153–1561. 2019.PubMed/NCBI View Article : Google Scholar
|
|
141
|
Zhao WK, Zhou Y, Xu TT and Wu Q:
Ferroptosis: Opportunities and challenges in myocardial
Ischemia-Reperfusion injury. Oxid Med Cell Longev.
2021(9929687)2021.PubMed/NCBI View Article : Google Scholar
|
|
142
|
Fang X, Wang H, Han D, Xie E, Yang X, Wei
J, Gu S, Gao F, Zhu N, Yin X, et al: Ferroptosis as a target for
protection against cardiomyopathy. Proc Natl Acad Sci USA.
116:2672–2680. 2019.PubMed/NCBI View Article : Google Scholar
|
|
143
|
Gao M, Monian P, Quadri N, Ramasamy R and
Jiang X: Glutaminolysis and transferrin regulate ferroptosis. Mol
Cell. 59:298–308. 2015.PubMed/NCBI View Article : Google Scholar
|
|
144
|
Ge ZD, Lian Q, Mao X and Xia Z: Current
status and challenges of NRF2 as a potential therapeutic target for
diabetic cardiomyopathy. Int Heart J. 60:512–520. 2019.PubMed/NCBI View Article : Google Scholar
|
|
145
|
Williams RE, Zweier JL and Flaherty JT:
Treatment with deferoxamine during ischemia improves functional and
metabolic recovery and reduces reperfusion-induced oxygen radical
generation in rabbit hearts. Circulation. 83:1006–1014.
1991.PubMed/NCBI View Article : Google Scholar
|
|
146
|
Drossos G, Lazou A, Panagopoulos P and
Westaby S: Deferoxamine cardioplegia reduces superoxide radical
production in human myocardium. Ann Thorac Surg. 59:169–172.
1995.PubMed/NCBI View Article : Google Scholar
|
|
147
|
Omiya S, Hikoso S, Imanishi Y, Saito A,
Yamaguchi O, Takeda T, Mizote I, Oka T, Taneike M, Nakano Y, et al:
Downregulation of ferritin heavy chain increases labile iron pool,
oxidative stress and cell death in cardiomyocytes. J Mol Cell
Cardiol. 46:59–66. 2009.PubMed/NCBI View Article : Google Scholar
|
|
148
|
Baba Y, Higa JK, Shimada BK, Horiuchi KM,
Suhara T, Kobayashi M, Woo JD, Aoyagi H, Marh KS, Kitaoka H and
Matsui T: Protective effects of the mechanistic target of rapamycin
against excess iron and ferroptosis in cardiomyocytes. Am J Physiol
Heart Circ Physiol. 314:H659–H668. 2018.PubMed/NCBI View Article : Google Scholar
|
|
149
|
Murphy JM, Czabotar PE, Hildebrand JM,
Lucet IS, Zhang JG, Alvarez-Diaz S, Lewis R, Lalaoui N, Metcalf D,
Webb AI, et al: The pseudokinase MLKL mediates necroptosis via a
molecular switch mechanism. Immunity. 39:443–453. 2013.PubMed/NCBI View Article : Google Scholar
|
|
150
|
Wu J, Huang Z, Ren J, Zhang Z, He P, Li Y,
Ma J, Chen W, Zhang Y, Zhou X, et al: Mlkl knockout mice
demonstrate the indispensable role of Mlkl in necroptosis. Cell
Res. 23:994–1006. 2013.PubMed/NCBI View Article : Google Scholar
|
|
151
|
Sun L, Wang H, Wang Z, He S, Chen S, Liao
D, Wang L, Yan J, Liu W, Lei X and Wang X: Mixed lineage kinase
domain-like protein mediates necrosis signaling downstream of RIP3
kinase. Cell. 148:213–227. 2012.PubMed/NCBI View Article : Google Scholar
|
|
152
|
Li L, Tong A, Zhang Q, Wei Y and Wei X:
The molecular mechanisms of MLKL-dependent and MLKL-independent
necrosis. J Mol Cell Biol. 13:3–14. 2021.PubMed/NCBI View Article : Google Scholar
|
|
153
|
Wang L, Wang T, Li H, Liu Q, Zhang Z, Xie
W, Feng Y, Socorburam T, Wu G, Xia Z and Wu Q: Receptor interacting
protein 3-Mediated necroptosis promotes Lipopolysaccharide-Induced
inflammation and acute respiratory distress syndrome in mice. PLoS
One. 11(e155723)2016.PubMed/NCBI View Article : Google Scholar
|
|
154
|
Oberst A, Dillon CP, Weinlich R, McCormick
LL, Fitzgerald P, Pop C, Hakem R, Salvesen GS and Green DR:
Catalytic activity of the caspase-8-FLIP(L) complex inhibits
RIPK3-dependent necrosis. Nature. 471:363–367. 2011.PubMed/NCBI View Article : Google Scholar
|
|
155
|
Dillon CP, Weinlich R, Rodriguez DA,
Cripps JG, Quarato G, Gurung P, Verbist KC, Brewer TL, Llambi F,
Gong YN, et al: RIPK1 blocks early postnatal lethality mediated by
caspase-8 and RIPK3. Cell. 157:1189–1202. 2014.PubMed/NCBI View Article : Google Scholar
|
|
156
|
Dannappel M, Vlantis K, Kumari S,
Polykratis A, Kim C, Wachsmuth L, Eftychi C, Lin J, Corona T,
Hermance N, et al: RIPK1 maintains epithelial homeostasis by
inhibiting apoptosis and necroptosis. Nature. 513:90–94.
2014.PubMed/NCBI View Article : Google Scholar
|
|
157
|
Zhang T, Zhang Y, Cui M, Jin L, Wang Y, Lv
F, Liu Y, Zheng W, Shang H, Zhang J, et al: CaMKII is a RIP3
substrate mediating ischemia- and oxidative stress-induced
myocardial necroptosis. Nat Med. 22:175–182. 2016.PubMed/NCBI View Article : Google Scholar
|
|
158
|
Bai J, Wang Q, Qi J, Yu H, Wang C, Wang X,
Ren Y and Yang F: Promoting effect of baicalin on nitric oxide
production in CMECs via activating the PI3K-AKT-eNOS pathway
attenuates myocardial ischemia-reperfusion injury. Phytomedicine.
63(153035)2019.PubMed/NCBI View Article : Google Scholar
|
|
159
|
Zhou H, Li D, Zhu P, Ma Q, Toan S, Wang J,
Hu S, Chen Y and Zhang Y: Inhibitory effect of melatonin on
necroptosis via repressing the Ripk3-PGAM5-CypD-mPTP pathway
attenuates cardiac microvascular ischemia-reperfusion injury. J
Pineal Res. 65(e12503)2018.PubMed/NCBI View Article : Google Scholar
|
|
160
|
Yang J, Zhang F, Shi H, Gao Y, Dong Z, Ma
L, Sun X, Li X, Chang S, Wang Z, et al: Neutrophil-derived advanced
glycation end products-Nε-(carboxymethyl) lysine promotes
RIP3-mediated myocardial necroptosis via RAGE and exacerbates
myocardial ischemia/reperfusion injury. FASEB J. 33:14410–14422.
2019.PubMed/NCBI View Article : Google Scholar
|
|
161
|
Ying L, Benjanuwattra J, Chattipakorn SC
and Chattipakorn N: The role of RIPK3-regulated cell death pathways
and necroptosis in the pathogenesis of cardiac
ischaemia-reperfusion injury. Acta Physiol (Oxf).
231(e13541)2021.PubMed/NCBI View Article : Google Scholar
|
|
162
|
Zhu P, Hu S, Jin Q, Li D, Tian F, Toan S,
Li Y, Zhou H and Chen Y: Ripk3 promotes ER stress-induced
necroptosis in cardiac IR injury: A mechanism involving calcium
overload/XO/ROS/mPTP pathway. Redox Biol. 16:157–168.
2018.PubMed/NCBI View Article : Google Scholar
|
|
163
|
Yin W, Wang C, Peng Y, Yuan W, Zhang Z,
Liu H, Xia Z, Ren C and Qian J: Dexmedetomidine alleviates
H2O2-induced oxidative stress and cell
necroptosis through activating of α2-adrenoceptor in H9C2 cells.
Mol Biol Rep. 47:3629–3639. 2020.PubMed/NCBI View Article : Google Scholar
|
|
164
|
Liu X, Zhang D, Dong X, Zhu R, Ye Y, Li L
and Jiang Y: Pharmacological activation of CB2 receptor protects
against ethanol-induced myocardial injury related to
RIP1/RIP3/MLKL-mediated necroptosis. Mol Cell Biochem. 474:1–14.
2020.PubMed/NCBI View Article : Google Scholar
|
|
165
|
Garcia-Dorado D, Rodríguez-Sinovas A,
Ruiz-Meana M and Inserte J: Protection against myocardial
ischemia-reperfusion injury in clinical practice. Rev Esp Cardiol
(Engl Ed). 67:394–404. 2014.PubMed/NCBI View Article : Google Scholar
|
|
166
|
Tian Y, Li H, Liu P, Xu JM, Irwin MG, Xia
Z and Tian G: Captopril pretreatment produces an additive
cardioprotection to isoflurane preconditioning in attenuating
myocardial ischemia reperfusion injury in rabbits and in humans.
Mediators Inflamm. 2015(819232)2015.PubMed/NCBI View Article : Google Scholar
|
|
167
|
Huang Z, Zhong X, Irwin MG, Ji S, Wong GT,
Liu Y, Xia ZY, Finegan BA and Xia Z: Synergy of isoflurane
preconditioning and propofol postconditioning reduces myocardial
reperfusion injury in patients. Clin Sci (Lond). 121:57–69.
2011.PubMed/NCBI View Article : Google Scholar
|
|
168
|
Xia Z, Gu J, Ansley DM, Xia F and Yu J:
Antioxidant therapy with Salvia miltiorrhiza decreases plasma
endothelin-1 and thromboxane B2 after cardiopulmonary bypass in
patients with congenital heart disease. J Thorac Cardiovasc Surg.
126:1404–1410. 2003.PubMed/NCBI View Article : Google Scholar
|
|
169
|
Heusch G: Molecular basis of
cardioprotection: Signal transduction in ischemic pre-, post-, and
remote conditioning. Circ Res. 116:674–699. 2015.PubMed/NCBI View Article : Google Scholar
|
